NAM EUN MI Professor
College of Medicine
She is a medical oncologist in School of Medicine and Ewha Womans University Mokdong Hospital. Her major interests are colorectal cancer, hepatobiliary cancer, and pancreatic cancer. In 2011, she visited Fred Hutchinson Cancer Research Center in Washington, USA and participated as a researcher in Colorectal cancer research team. Now, she is working as an academician of Korean Association for Clinical Oncology.
- Esther Building #929
- 02-6986-1640
Research Record
- Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial BMC Cancer, 2023, v.23 no.1, 734
- Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort Cancers, 2022, v.14 no.19, 4839
- Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family members SUPPORTIVE CARE IN CANCER, 2020, v.28 no.6, 2959-2967
- Clinical Practice Guideline for Care in the Last Days of Life 한국호스피스완화의료학회지, 2020, v.23 no.3, 103-113
- Peroxiredoxin 3 has important roles on arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line via hyperoxidation of mitochondrial specific reactive oxygen species Molecules and Cells, 2020, v.43 no.9, 813-820
- Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, v.57 no.4, 774-782
- Do Korean Medical Schools Provide Adequate End-of-Life Care Education? A Nationwide Survey of the Republic of Korea’s End-of-Life Care Curricula 한국호스피스완화의료학회지, 2019, v.22 no.4, 207~218
- Efficacy of a Decision Aid Consisting of a Video and Booklet on Advance Care Planning for Advanced Cancer Patients: Randomized Controlled Trial Journal of Pain and Symptom Management, 2019, v.58 no.6, 940-9.48E04
- Factors That Influence Attitudes Toward End-of-Life Care Among Medical Students: Nationwide Survey for Fourth-Year Korean Medical Students AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2019, v.36 no.6, 460-465
- Mapping of local recurrence after pancreaticoduodenectomy for distal extrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy BRITISH JOURNAL OF RADIOLOGY, 2019, v.92 no.1100, 20190285
- The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study The Korean journal of internal medicine, 2019, v.34 no.1, 165-177
- Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study CANCER COMMUNICATIONS, 2018, v.38
- Comparison of attitudes towards five end-of-life care interventions (active pain control, withdrawal of futile life-sustaining treatment, passive euthanasia, active euthanasia and physician-assisted suicide): a multicentred cross-sectional survey of Korean patients with cancer, their family caregivers, physicians and the general Korean population BMJ OPEN, 2018, v.8 no.9, e020519
- Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, v.33 no.49, UNSP e327
- Prognostic significance of survivin expression and combined analysis with cancer stem cell and epithelial–mesenchymal transition-related markers in patients with rectal cancer undergoing preoperative chemoradiotherapy Anticancer Research, 2018, v.38 no.12, 6881-6889
- 심폐소생술 금지 동의 후 사망한 환자의 현황과 연명의료 실태 조사: 단일 의료기관 경험 한국호스피스완화의료학회지, 2018, v.21 no.2, 51~57
- Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy International Journal of Clinical Oncology, 2017, v.22 no.6, 1-7
- Role of adjuvant radiotherapy for localized extrahepatic bile duct cancer BRITISH JOURNAL OF RADIOLOGY, 2017, v.90 no.1071
- Salvage radiotherapy for locoregionally recurrent extrahepatic bile duct cancer after radical surgery British Journal of Radiology, 2017, v.90 no.1080
- 임종돌봄에 대한 교육의 필요성: 2개 대학병원의 인턴을 대상으로 예비 분석 한국호스피스완화의료학회지, 2017, v.20 no.2, 111~121
- Germ Cell Tumor Targeting Chemotherapy in Gastric Adenocarcinoma with an Endodermal Sinus Tumor Component: A Case Report Chemotherapy, 2016, June 29, 2016, 54-57
- Inhibition of beta-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line PLOS ONE, 2016, v.11 no.5
- MITOCHONDRIAL SPECIFIC ROS HYPEROXIDATION VIA PEROXIREDOXIN III HAS IMPORTANT ROLES ON ARSENIC TRIOXIDE INDUCED APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA HAEMATOLOGICA, 2016, v.101, 672-672
- Manipulation of beta-catenin pathway to overcome endocrine resistance in breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 2015, v.33 no.15
- Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, v.75 no.4, 757-762
- CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer GASTROENTEROLOGY, 2014, v.147 no.3, 637-645
- Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, v.73 no.1, 125-130
- Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer TUMORI, 2014, v.100 no.1, 80-86
- Treatment outcomes of gemcitabine alone versus gemcitabine plus platinum for advanced biliary tract cancer: a Korean Cancer Study Group retrospective analysis CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, v.74 no.6, 1291-1296
Courses
-
2024-1st
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
-
2023-2nd
-
Patient-Doctor-Society Ⅱ(Medical Ethics and Communication)
- Subject No 37609Class No 01
- 1Year ( 1Credit , 18Hour)
- Major Requisite
-
Hematology and Oncology
- Subject No 37624Class No 01
- 2Year ( 3Credit , 65Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
End of Life Care (EOL)
- Subject No 37657Class No 01
- 3Year ( 1Credit , 22Hour)
- Major Requisite
-
-
2023-1st
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
-
2022-2nd
-
Patient-Doctor-Society Ⅱ(Medical Ethics and Communication)
- Subject No 37609Class No 01
- 1Year ( 1Credit , 18Hour)
- Major Requisite
-
Hematology and Oncology
- Subject No 37624Class No 01
- 2Year ( 3Credit , 65Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
End of Life Care (EOL)
- Subject No 37657Class No 01
- 3Year ( 1Credit , 22Hour)
- Major Requisite
-
-
2022-1st
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
-
2021-2nd
-
Patient-Doctor-Society Ⅱ(Medical Ethics and Communication)
- Subject No 37609Class No 01
- 1Year ( 1Credit , 18Hour)
- Major Requisite
-
Hematology and Oncology
- Subject No 37624Class No 01
- 2Year ( 3Credit , 65Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
End of Life Care (EOL)
- Subject No 37657Class No 01
- 3Year ( 1Credit , 22Hour)
- Major Requisite
-
-
2021-1st
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
End of Life Care:EOL
- Subject No K10096Class No 01
- Year ( 1Credit , 25Hour)
-
Academic Background
Ewha Womans University 의학박사(의학과)